PotentiaMetrics Announces Additions to its Clinical Advisory Board with Doctors Carolyn Presley and Michael Papagikos

Share Article

MyCancerJourney Empowers Patients with Actionable Information while Improving Outcomes.

It is exciting to be a part of an innovative company that is using advanced analytics and machine learning to bring personalized decision-making to patients.

POTENTIAMETRICS, an Austin, TX based healthcare data and artificial intelligence company, announced the addition of Carolyn Presley, M.D. MHS and Michael Papagikos, M.D to the ranks of its stellar group of specialists, MDs and medical researchers committed to empowering patients with the strongest data in cancer.

MyCancerJourney was developed by researchers at Washington University in St. Louis School of Medicine to provide patient-specific survival estimates, improve outcomes and empower patients. Dr. Presley stated, “It is exciting to be a part of an innovative company that is using advanced analytics and machine learning to bring personalized decision-making to patients.”

Carolyn Presley, M.D. MHS is a thoracic and geriatric oncologist, specializing in the treatment of older adults with lung cancer. Dr. Presley received her medical training at Dartmouth Medical School in Hanover, New Hampshire, and completed her Master of Health Science at Yale School of Medicine.

Dr. Presley is an assistant professor in medical oncology at the James Thoracic Oncology Center, The Ohio State University School of Medicine. Her research focuses on optimizing patients’ functional status and maximizing quality of life for older adults with lung cancer. Dr. Presley research has been published in numerous journals, including JAMA, Journal of Clinical Oncology and the Journal of Geriatric Oncology. In addition, she serves as a member in the American Society of Clinical Oncology, the Cancer and Aging Research Group and the American Geriatrics Society. Dr. Presley also works as a peer reviewer for journals such as the Journal of the National Comprehensive Cancer Network, The Journal of Geriatric Oncology, the Journal of Cancer Survivorship and The Oncologist.

Kendall Qualls, Chief Commercial Officer, stated, “it’s an honor to have someone of Dr. Presley’s stature and dedication embrace advanced analytics and AI to solve common problems patients face every day when they learn of their cancer diagnosis.”

“Additionally, we are delighted to announce the appointment of Michael Papagikos, M.D. as a member of the Clinical Advisory Board to PotentiaMetrics. Dr. Papagikos is a highly respected radiation oncologist who has treated thousands of patients throughout his career. His addition to the CAB brings a depth of clinical insight that enhances the broad expertise of the multi-disciplinary board,” said Robert Palmer, CEO of PotentiaMetrics.

Dr. Papagikos is a radiation oncologist in Wilmington, North Carolina specializing in the management of lung and prostate cancer. He is very committed to offering and conducting high quality clinical cancer research in the community setting and underserved populations through physician initiated and national cooperative group studies. He is affiliated with the New Hanover Regional Medical Center and serves as the Director of the Multi-Disciplinary Lung Program. He received his medical degree and residency training from Wake Forest School of Medicine.

About PotentiaMetrics
PotentiaMetrics develops unique outcomes and insights solutions to support more informed, value-based treatment decisions that lead to better outcomes and reduced costs.

To learn more about PotentiaMetrics, visit: http://www.potentiametrics.com
To learn more about MyCancerJourney, visit: http://www.mycancerjourney.com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Christin Palmer
@PotentiaMetrics
Follow >
PotentiaMetrics
Like >
Visit website

Media